Search research articles
Contact Us
Filters
Showing results (611-620 of 717) with videos related to
Page
of 72
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 13, 2019
Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial
Seth A Rosenthal, Chen Hu, Oliver Sartor, et al.
The Lancet. Haematology
|
February 28, 2020
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project
Christopher P Fox, Monica Civallero, Young-Hyeh Ko, et al.
Advances in Radiation Oncology
|
April 20, 2026
The Association of p27 With Prostate Cancer Outcomes: A Secondary Analysis of NRG/RTOG 8610 and 9202
Krishnan R Patel, Stephanie L Pugh, Jeffry P Simko, et al.
Blood
|
July 31, 2020
Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era
Sabela Bobillo, Erel Joffe, Jessica A Lavery, et al.
Leukemia & Lymphoma
|
July 2, 2025
Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis
Efrat Luttwak, Edith Tama Robin, Esther Drill, et al.
Blood Advances
|
September 10, 2021
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data
Steven M Horwitz, Julia J Scarisbrick, Reinhard Dummer, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
July 1, 1996
The NIMH Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study: background and methodology
B B Lahey, E W Flagg, H R Bird, et al.
The New England Journal of Medicine
|
February 5, 2025
CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in <i>TP53</i>
Karlo Perica, Nayan Jain, Michael Scordo, et al.
American Journal of Hematology
|
July 12, 2021
Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts
Neha Mehta-Shah, Matthew A Lunning, Alison J Moskowitz, et al.
Blood Advances
|
April 3, 2025
Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma
Niloufer Khan, Parastoo B Dahi, Farhad Khimani, et al.
Page
of 72
Search research articles
Search
Showing results (611-620 of 717) with videos related to
Sort By:
Page
of 72
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 13, 2019
Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial
Seth A Rosenthal, Chen Hu, Oliver Sartor, et al.
The Lancet. Haematology
|
February 28, 2020
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project
Christopher P Fox, Monica Civallero, Young-Hyeh Ko, et al.
Advances in Radiation Oncology
|
April 20, 2026
The Association of p27 With Prostate Cancer Outcomes: A Secondary Analysis of NRG/RTOG 8610 and 9202
Krishnan R Patel, Stephanie L Pugh, Jeffry P Simko, et al.
Blood
|
July 31, 2020
Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era
Sabela Bobillo, Erel Joffe, Jessica A Lavery, et al.
Leukemia & Lymphoma
|
July 2, 2025
Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis
Efrat Luttwak, Edith Tama Robin, Esther Drill, et al.
Blood Advances
|
September 10, 2021
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data
Steven M Horwitz, Julia J Scarisbrick, Reinhard Dummer, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
July 1, 1996
The NIMH Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study: background and methodology
B B Lahey, E W Flagg, H R Bird, et al.
The New England Journal of Medicine
|
February 5, 2025
CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in <i>TP53</i>
Karlo Perica, Nayan Jain, Michael Scordo, et al.
American Journal of Hematology
|
July 12, 2021
Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts
Neha Mehta-Shah, Matthew A Lunning, Alison J Moskowitz, et al.
Blood Advances
|
April 3, 2025
Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma
Niloufer Khan, Parastoo B Dahi, Farhad Khimani, et al.
Page
of 72